CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3023% above fair value
$79.81−1.36 (-1.68%)
Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –
CareDx operating margin
Operating margin is operating income as a percentage of revenue.
CareDx's operating margin for the twelve months ending Sep 30, 2026 was 23.4%. For fiscal 2025 it was -8.1%, against 12.2% the year before. The highest annual figure on record is 12.2% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8.1% | −20.3 |
| FY2024 | Dec 31, 2024 | 12.2% | +84.8 |
| FY2023 | Dec 31, 2023 | -72.5% | −48.5 |
| FY2022 | Dec 31, 2022 | -24.0% | −14.0 |
| FY2021 | Dec 31, 2021 | -10.0% | +1.7 |
| FY2020 | Dec 31, 2020 | -11.7% | +7.6 |
| FY2019 | Dec 31, 2019 | -19.3% | +1.0 |
| FY2018 | Dec 31, 2018 | -20.3% | +21.7 |
| FY2017 | Dec 31, 2017 | -42.0% | +49.9 |
| FY2016 | Dec 31, 2016 | -91.9% | −49.5 |
| FY2015 | Dec 31, 2015 | -42.4% | −47.0 |
| FY2014 | Dec 31, 2014 | 4.6% | +8.5 |
| FY2013 | Dec 31, 2013 | -3.9% | +7.6 |
| FY2012 | Dec 31, 2012 | -11.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 5.8% | +6.1 |
| Q2 FY2026 | Jun 30, 2026 | 85.8% | +98.6 |
| Q1 FY2026 | Mar 31, 2026 | 1.0% | +16.8 |
| Q4 FY2025 | Dec 31, 2025 | -5.6% | −103.0 |
| Q3 FY2025 | Sep 30, 2025 | -0.2% | +16.3 |
| Q2 FY2025 | Jun 30, 2025 | -12.8% | −4.9 |
| Q1 FY2025 | Mar 31, 2025 | -15.8% | +15.5 |
| Q4 FY2024 | Dec 31, 2024 | 97.5% | +284.5 |
| Q3 FY2024 | Sep 30, 2024 | -16.6% | +26.3 |
| Q2 FY2024 | Jun 30, 2024 | -7.9% | +31.4 |
| Q1 FY2024 | Mar 31, 2024 | -31.3% | +0.2 |
| Q4 FY2023 | Dec 31, 2023 | -187.0% | −163.8 |
| Q3 FY2023 | Sep 30, 2023 | -42.8% | −21.0 |
| Q2 FY2023 | Jun 30, 2023 | -39.3% | −12.4 |
| Q1 FY2023 | Mar 31, 2023 | -31.5% | −7.5 |
| Q4 FY2022 | Dec 31, 2022 | -23.2% | −3.8 |
| Q3 FY2022 | Sep 30, 2022 | -21.8% | −10.3 |
| Q2 FY2022 | Jun 30, 2022 | -26.9% | −20.5 |
| Q1 FY2022 | Mar 31, 2022 | -24.0% | −22.7 |
| Q4 FY2021 | Dec 31, 2021 | -19.4% | −14.2 |
| Q3 FY2021 | Sep 30, 2021 | -11.5% | −6.1 |
| Q2 FY2021 | Jun 30, 2021 | -6.4% | +19.5 |
| Q1 FY2021 | Mar 31, 2021 | -1.3% | +13.7 |
| Q4 FY2020 | Dec 31, 2020 | -5.2% | +10.2 |
| Q3 FY2020 | Sep 30, 2020 | -5.4% | +14.5 |
| Q2 FY2020 | Jun 30, 2020 | -25.8% | −4.1 |
| Q1 FY2020 | Mar 31, 2020 | -15.0% | +5.8 |
| Q4 FY2019 | Dec 31, 2019 | -15.5% | −5.2 |
| Q3 FY2019 | Sep 30, 2019 | -20.0% | −7.1 |
| Q2 FY2019 | Jun 30, 2019 | -21.8% | +7.5 |
| Q1 FY2019 | Mar 31, 2019 | -20.8% | +16.5 |
| Q4 FY2018 | Dec 31, 2018 | -10.3% | +24.0 |
| Q3 FY2018 | Sep 30, 2018 | -12.8% | +18.9 |
| Q2 FY2018 | Jun 30, 2018 | -29.2% | +0.7 |
| Q1 FY2018 | Mar 31, 2018 | -37.3% | +36.5 |
| Q4 FY2017 | Dec 31, 2017 | -34.3% | +139.4 |
| Q3 FY2017 | Sep 30, 2017 | -31.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -29.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -73.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -173.7% | – |
See a number that looks wrong?